Structure
Rabeprazole Chemical Structure – C18H21N3O3S
Mode of action
A dose-dependent suppression of both basal and induced gastric acid secretion is caused by rabeprazole's inhibition of the H+, K+ ATPase of the coated gastric cells.
Uses
Duodenal ulcers and gastroesophageal reflux disease are treated with rabeprazole.
Zollinger-Ellison syndrome, an illness in which the stomach secretes excessive amounts of acid are also treated with rabeprazole.